Cargando…
Anti-Trypanosoma cruzi Cross-Reactive Antibodies Detected at High Rate in Non-Exposed Individuals Living in Non-Endemic Regions: Seroprevalence and Association to Other Viral Serologies
Cross-reactive antibodies are characterized by their recognition of antigens that are different from the trigger immunogen. This happens when the similarity between two different antigenic determinants becomes adequate enough to enable a specific binding with such cross-reactive antibodies. In the p...
Autores principales: | Saba, Esber S., Gueyffier, Lucie, Dichtel-Danjoy, Marie-Laure, Pozzetto, Bruno, Bourlet, Thomas, Gueyffier, François, Mekki, Yahia, Pottel, Hans, Sabino, Ester C., Vanhems, Philippe, Zrein, Maan A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3775794/ https://www.ncbi.nlm.nih.gov/pubmed/24069315 http://dx.doi.org/10.1371/journal.pone.0074493 |
Ejemplares similares
-
Trypanosoma-Cruzi Cross-Reactive Antibodies Longitudinal Follow-Up: A Prospective Observational Study in Hematopoietic Stem Cell Transplantation
por: Saba, Esber S., et al.
Publicado: (2015) -
Development of a Novel Multiplex Immunoassay Multi-cruzi for the Serological Confirmation of Chagas Disease
por: Granjon, Elodie, et al.
Publicado: (2016) -
A novel antibody surrogate biomarker to monitor parasite persistence in Trypanosoma cruzi-infected patients
por: Zrein, Maan, et al.
Publicado: (2018) -
Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice
por: Nagarkatti, Rana, et al.
Publicado: (2014) -
Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure
por: Francisco, Amanda Fortes, et al.
Publicado: (2022)